Nefextinib is an active pharmaceutical ingredient under investigation in clinical trials for specific oncological research. It is a synthetic compound with a complex heterocyclic structure containing fluorine and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2070931-57-4
MAX-40279 HEMIFUMARATE
pharmaceutical raw material
MAX-40279 hemiadipate
pharmaceutical intermediate
Methyl (S)-phenyl[(R)-piperidin-2-yl]acetate
pharmaceutical raw material
QUININE SULFATE DIHYDRATE
pharmaceutical raw material
Desfesoterodine
pharmaceutical raw material
Propofol
pharmaceutical raw material
7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-piperidin-4-ylpyrazol-4-yl)thieno[3,2-d]pyrimidin-2-amine
AVIOBQFPAGEICQ-UHFFFAOYSA-N
CC1=C(C2=NC(=NC=C2S1)NC3=CN(N=C3)C4CCNCC4)C5=C(C=C(C=C5)F)OC